.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Accenture
Colorcon
Mallinckrodt
US Department of Justice
Argus Health
Novartis
McKesson
Teva
Deloitte

Generated: June 28, 2017

DrugPatentWatch Database Preview

AKPENTOLATE Drug Profile

« Back to Dashboard

What is the patent landscape for Akpentolate, and when can generic versions of Akpentolate launch?

Akpentolate is a drug marketed by Akorn and is included in two NDAs.

The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.

Summary for Tradename: AKPENTOLATE

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list27
Patent Applications: see list568
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AKPENTOLATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
AKPENTOLATE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC040164-001Jan 13, 1997ATRXNoNo► Subscribe► Subscribe
Akorn
AKPENTOLATE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC040165-001Jan 13, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Novartis
Medtronic
Chubb
Johnson and Johnson
Citi
US Army
QuintilesIMS
Healthtrust
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot